Vivus, Inc.: Drug Recall
Recall #D-0896-2023 · 06/23/2023
Class III: Low Risk
Recall Details
- Recall Number
- D-0896-2023
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- Vivus, Inc.
- Status
- Ongoing
- Date Initiated
- 06/23/2023
- Location
- Campbell, CA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4240 bottles
Reason for Recall
Failed Stability Specifications
Product Description
PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Campbell, CA 95008, UPC: N3 62541-401-10 5, NDC 62541-401-10,
Distribution Pattern
Nationwide within the United States
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.